Pancreatic cancer and hypercalcemia associated with von Recklinghausen's disease

Journal of Gastroenterology

Volumn 31, Issue 5, 1996, Pages 728-731

  Yamamoto, Mitsuyoshi ^a   Nakano, Shigekazu ^a   Mugikura, Masatoshi ^a   Tachibana, Issei ^a   Ogami, Yoshimitsu ^a   Otsuki, Makoto ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Humoral hypercalcemia of malignancy; Pancreatic cancer; Von Recklinghausen's disease

Indexed keywords

CALCIUM; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BONE SCINTISCANNING; CALCIUM BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; HYPERCALCEMIA; LIVER METASTASIS; MALE; NEUROFIBROMATOSIS; PANCREAS CANCER; PANCREAS DUCT STENOSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; HYPERCALCEMIA; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; PANCREATIC NEOPLASMS;

EID: 0029906230     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02347625     Document Type: Article

References (28)

1. Vernes S, Caviness JR. Neurocutaneous syndromes. In: Wilson JD, Braunwald EB, Isselbacher KL, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK (eds) Harrison's principles of internal medicine. 12th ed. New York: McGraw-Hill, 1991;2055-2056.
2. Paraf F, Poynard T, Bedossa P, et al. Adenocarcinoma of Vater's ampulla and von Recklinghausen disease. Ann Int Med 1987; 107:785.
3. Sprengers DP, Knockaert DC, Steenbergen WV, et al. Primary bile duct cancer and von Recklinghausen disease. Ann Int Med 1987;106:772.
4. Niiyama T, Toujinbara H, Sacki K, et al. Two cases of von Recklinghausen's disease with malignant tumor (in Japanese). Jpn J Gastroenterol 1989;86:2474-2479.
5. Shimizu Y, Tsuchiya S, Watanabe S, et al. von Recklinghausen's disease with lung cancer derived from the wall of emphysematous bullae. Int Med 1994;33:167-171.
6. Broadus AE, Mangin M, Ikeda K, et al. Humoral hypercalcemia of cancer. N Engl J Med 1988;319:556-563.
7. Ratcliffe WA, Norbury S, Heath DA, et al. Development and validation of an immunoradiometric assay for parathyrin-related protein in unextracted plasma. Clin Chem 1991;37:678-685.
8. Nagata N, Kugai N, Maemura M, et al. Enhancement of cyclic adenosine monophosphate content in bone cells by the factor extracted from a pancreatic cancer associated with hypercalcemia. Metabolism 1986;35:529-534.
9. Birkeland KI, Gallefoss F, Olsson S, et al. Primary hyper-parathyroidism or hypercalcemia of malignancy? Scand J Clin Lab Invest 1992;52:347-349.
10. Miraliakbari BA, Asa SL, Boudreau SF. Parathyroid hormone-like peptide in pancreatic endocrine carcinoma and adenocarcinoma associated with hypercalcemia. Hum Pathol 1992;23:884-887.
11. Tachibana I, Nakano S, Akiyama T, et al. Parathyroid hormone-related protein mediates hypercalcemia in an exocrine pancreatic cancer. Am J Gastroenterol 1994;89:1580-1581.
12. Schonebeck J, Ljungberg O. Recklinghausen's disease: A multifaceted syndrome. Acta Pathol Microbiol Scand 1970;78:437-442.
13. Horita T, Katou T, Tanaka R, Otsuka N. The neuronotropic factor (NTF) in neurofibroma (von-Recklinghausen's disease) (in Japanese). Seikagaku 1988;60:635.
14. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis: Survival and malignant nenoplasms. N Engl J Med 1986;314:1010-1015.
15. Kossak DA, Gonzales CL, Doria US. (in Portuguese with English abstract). Arquiv hospitals da Santa Casa del São Paulo 1969;15:19-20.
16. Knight WA, Murphy WK, Gottlieb JA. Neurofibromatosis associated with malignant neurofibromas. Arch Dermatol 1973;107:747-750.
17. Keller RT, Logan GM. Adenocarcinoma of the pancrease associated with neurofibromatosis. Cancer 1977;39:1246-1264.
18. Niv Y, Abuavid S, Oren M. Adenocarcinoma of pancreas and duodenum associated with cutaneous neurofibromatosis. Am J Med 1987;82:384-385.
19. Connolly MM, Dawson PJ, Michelassi F, et al. Survival in 1001 patients with carcinoma of the pancreas Ann Surg 1987;206:366-373.
20. Sands MJ, McDonough MT, Cohen AM, et al. Fatal malignant degeneration in multiple neurofibromatosis. J Am Med Assoc 1975;233:1381-1382.
21. Storm HH, Jensen OM, Ewertz M, et al. Multiple primary cancers in Denmark, 1943-80. Natl Cane Inst Monoger 1985;68:411-430.
22. Cawthon RM, Weiss R, Xu G, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990;62:193-201.
23. Xu G, O'Connell P, Viskochil D, et al. The neurofibrosis type 1 gene encodes a protein related to GAP. Cell 1990;62:559-608.
24. Adrai H, Lowy DR, Wilumsen BM, Der CJ. Guanosine triphosphate activating protein (GAP) interacts with the p21 ras effector binding domain. Science 1988;240:518-521.
25. Vassilopoulou-Sellin R, Newman BM, Taylor SH, et al. Incidence of hypercaleamia in patients with malignancy referred to a comprehensive cancer center. Cancer 1993;71:1309-1312.
26. Sato K, Fujii K, Kasono K, et al. Parathyroid hormone related protein and interleukin-1 α synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in vivo. Endocrinology 1989;124:2172-2178.
27. Yoneda T, Nakai M, Moriyama K, et al. Neutralizing antibodies to human interleukin 6 reverse hypercalcerma associated with a human squamous carcinoma. Cancer Res 1993;53:737-740.
28. Yoneda T, Alsina MA, Chavez JB, et al. Evidence that tumor necrosis factor play a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia and leukocytosis in a human tumor in nude mice. J Clin Invest 1991;87:977-985.